What You Should Know:
– HeartX, a digital health accelerator powered by HealthTech Arkansas and MedAxiom along with eleven leading cardiology practices in Arkansas and around the country — has selected the five healthcare companies that…
Continue Reading
Mendel.ai, a startup that uses artificial intelligence to help structure medical information, announced the launch of Hypercube, an AI-powered platform that integrates structured and unstructured text data, democratizes analytics, and allows a user to ask…
Continue Reading
Mount Sinai has teamed up with the Chiba Institute of Technology to integrate artificial intelligence (AI) into cardiovascular research, aiming to accelerate patient care and treatment innovations. This collaboration holds global significance in addressing…
Continue Reading
The Icahn School of Medicine at Mount Sinai has signed a memorandum of understanding with the Chiba Institute of Technology to use artificial intelligence to enhance clinical trials for cardiovascular disease, advance patient care…
Continue Reading
What You Should Know:
H1, the leading source of truth for global Healthcare Professional, clinical, scientific, and research information, today announced the launch of GenosAI, a new generative AI tool seamlessly embedded into its clinical…
Continue Reading
What You Should Know:
– Medable Inc., a technology provider for modern clinical trials forms an enterprise partnership with Pluto Health, a smart care coordination services company.
– The partnership brings together two best-in-class technology solutions…
Continue Reading
AI, machine learning, and NLP are revolutionizing healthcare through data analysis. Premier Inc. exemplifies this transformation, showcasing how AI optimizes patient selection for trials, identifies diseases like lung cancer, and enhances dementia care. By…
Continue Reading
Hospitals and health systems are using artificial intelligence to advance patient selection for clinical trials, avoid healthcare supply chain disruptions, uncover early-stage disease, decrease patient wait times – and those are just a few…
Continue Reading
Dr. Jose E Vidal who is currently the CEO of CytoImmune Therapeutics, a company at the forefront of a novel natural killer cell therapy for lung cancer, currently in phase 1 clinical trials joins…
Continue Reading
What You Should Know:
Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced an agreement with Janssen Research & Development, LLC (Janssen), a Johnson & Johnson company,…
Continue Reading
